Carisma Therapeutics Inc. Deferred Revenue Recognized
Carisma Therapeutics Inc. reported Deferred Revenue Recognized of -$44.98 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2025-11-12
- Carisma Therapeutics Inc. contract with customer, liability, revenue recognized for the quarter ending 2025-03-31 was -$3.73M.
- Carisma Therapeutics Inc. contract with customer, liability, revenue recognized for the quarter ending 2024-03-31 was -$3.40M.
- Carisma Therapeutics Inc. contract with customer, liability, revenue recognized for the quarter ending 2023-03-31 was -$3.24M.
- Carisma Therapeutics Inc. contract with customer, liability, revenue recognized for the quarter ending 2022-03-31 was -$822.00K.
- Carisma Therapeutics Inc. contract with customer, liability, revenue recognized for fiscal 2024 was -$17.63M.
- Carisma Therapeutics Inc. contract with customer, liability, revenue recognized for fiscal 2023 was -$14.92M.
- Carisma Therapeutics Inc. contract with customer, liability, revenue recognized for fiscal 2022 was -$9.83M.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$44.98M 10-Q · filed 2025-11-12 | |||
| 2025-06-30 | -$3.73M 10-Q · filed 2025-08-07 | |||
| 2025-03-31 | -$3.73M 10-Q · filed 2025-05-13 | |||
| 2024-12-31 | -$17.63M 10-K · filed 2025-03-31 | |||
| 2024-09-30 | -$13.98M 10-Q · filed 2025-11-12 | |||
| 2024-06-30 | -$10.59M 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | -$3.40M 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | -$14.92M 10-K · filed 2025-03-31 | |||
| 2023-09-30 | -$10.63M 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | -$6.80M 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | -$3.24M 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | -$9.83M 10-K · filed 2024-04-01 | |||
| 2022-09-30 | -$6.10M 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | -$3.52M 10-Q · filed 2023-08-10 | |||
| 2022-03-31 | -$822.00K 10-Q · filed 2023-05-11 |